CUSIP: 67457L100
Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
352,340
-
Share change
-
+337,690
-
Total reported value
-
$2,168,248
-
Price per share
-
$6.16
-
Number of holders
-
25
-
Value change
-
+$2,078,333
-
Number of buys
-
24
Quarterly Holders Quick Answers
What is CUSIP 67457L100?
CUSIP 67457L100 identifies OCAT - OCATA THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2015
-
Previous quarter:
Q4 2014
Recent filing periods for CUSIP 67457L100:
Institutional Holders of OCATA THERAPEUTICS INC - COM (OCAT) as of Q1 2015
As of 31 Mar 2015,
OCATA THERAPEUTICS INC - COM (OCAT) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
352,340 shares.
The largest 10 holders included
SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, KCG Holdings, Inc., BlueCrest Capital Management Ltd, JANE STREET GROUP, LLC, GOLDMAN SACHS GROUP INC, Commonwealth Equity Services, Inc, MARK SHEPTOFF FINANCIAL PLANNING, LLC, and Colonial Trust Advisors.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.